StockData
Puma Biotechnology, Inc. logo

Puma Biotechnology, Inc. (PBYI) stock

PBYINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 14/3019% below fair value
$7.22+0.08 (+1.12%)

Close on Nov 18, 2026Market cap $372.70MP/E 13.9Yield –

Puma Biotechnology market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Puma Biotechnology's market cap was $412.91M on Nov 11, 2026, against $254.44M a year earlier. Over the last 5 years it ranged from $87.20M to $533.51M, with a median of $170.42M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$412.91M+37.7%
2025Dec 31, 2025$299.79M+100.3%
2024Dec 31, 2024$149.66M-27.3%
2023Dec 29, 2023$205.86M+6.7%
2022Dec 30, 2022$192.93M+55.3%
2021Dec 31, 2021$124.22M-69.5%
2020Dec 31, 2020$407.54M+19.6%
2019Dec 31, 2019$340.76M-56.1%
2018Dec 31, 2018$775.85M-79.0%
2017Dec 29, 2017$3.70B+270.3%
2016Dec 30, 2016$997.84M-60.7%
2015Dec 31, 2015$2.54B-55.4%
2014Dec 31, 2014$5.70B+91.9%
2013Dec 31, 2013$2.97B+690.5%
2012Dec 31, 2012$375.75M–

More Puma Biotechnology figures

See a number that looks wrong?